Hans D. Nischalke
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
The challenge of replicating putative genetic risk factors in a population-based database.
Journal: Journal of gastroenterology and hepatology
Published: April 03, 2024
Role of PAR1 -506 deletion/insertion polymorphism in primary sclerosing cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 11, 2023
Catecholamines and inflammation in advanced liver disease: more closely intertwined than expected?
Journal: Gut
Published: June 20, 2023
Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.
Journal: International journal of molecular sciences
Published: November 02, 2022
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: August 15, 2022
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: July 12, 2022
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Journal: Gut
Published: February 15, 2022
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.
Journal: Hepatology communications
Published: September 01, 2021
Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
Journal: Hepatology communications
Published: May 07, 2021
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
Journal: Cell reports
Published: March 22, 2021
Last Updated: 09/26/2026